CareDx Inc.

CareDx Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.21
Market Cap
$1.49 B
Shares Outstanding
42.12 M
Public Float
35.72 M

Profile

Address
3260 Bayshore Boulevard
Brisbane California 94005
United States
Employees -
Website http://www.caredxinc.com
Updated 07/08/2019
CareDx, Inc. operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. It focuses on discovery, development, and commercialization of diagnostic surveillance solutions. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test.

Financials

View All

Peter K. Maag
President, Chief Executive Officer & Director
Amy P. Abernethy
Director